Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026)

Olema Pharmaceuticals' (OLMA) quarterly Treasury Shares came in at $402807.0 in Q1 2026, little changed on a QoQ basis from $403000.0 in Q3 2024.

Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026) Analysis & Trends

Olema Pharmaceuticals (OLMA) has 6 years of Treasury Shares data on file, last reported at $402807.0 in Q1 2026.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $402807.0 in Q1 2026; TTM through Mar 2026 was $402807.0, a N/A change from a year earlier, with the FY2023 full-year figure at $403000.0, down 43.24% from the prior year.
  • Treasury Shares for Q1 2026 stood at $402807.0, roughly flat from $403000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for OLMA reached as high as $710000.0 in Q4 2022 and fell as low as $40352.0 in Q1 2024.
  • Historically, Treasury Shares has averaged $339511.5 across 4 years, with a median of $394548.0 in 2022.
  • On a YoY basis, Treasury Shares climbed as much as 172.38% in 2024 and fell as far as 83.64% in 2024.
  • Year by year, Treasury Shares stood at $710000.0 in 2022, then slumped by 43.24% to $403000.0 in 2023, then changed by 0.0% to $403000.0 in 2024, then retreated by 0.05% to $402807.0 in 2026.
  • Per Business Quant data, the three most recent Treasury Shares figures were $402807.0 in Q1 2026, $403000.0 in Q3 2024, and $40352.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -21,709.08
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 265,401.92
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 5.14 Mn
10 Olema Pharmaceuticals 1.21 Bn 1.21 Bn - 402,807.00

Historic Data

Download Data
DateValue
Mar 31, 2026 402,807.00
Mar 31, 2026 402,807.00
Sep 30, 2024 403,000.00
Sep 30, 2024 403,000.00
Mar 31, 2024 40,352.00
Mar 31, 2024 40,352.00
Dec 31, 2023 403,000.00
Dec 31, 2023 403,000.00
Sep 30, 2023 147,956.00
Sep 30, 2023 147,956.00
Jun 30, 2023 197,274.00
Jun 30, 2023 197,274.00
Mar 31, 2023 246,593.00
Mar 31, 2023 246,593.00
Dec 31, 2022 710,000.00
Dec 31, 2022 710,000.00
Sep 30, 2022 345,230.00
Sep 30, 2022 345,230.00
Jun 30, 2022 394,548.00
Jun 30, 2022 394,548.00